Manchado, Eusebio
Novartis (Switzerland) · Memorial Sloan Kettering Cancer Center · Novartis Institutes for BioMedical Research
6 papers on CoChatORCID 0009-0009-3170-9788
Most cited papers
- Verified
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
Maddalo, D., Manchado, E., Concepcion, C. P., Bonetti, C., Vidigal, J. A., Han, Y.-C., Ogrodowski, P., Crippa, A., Rekhtman, N., de Stanchina, E., et al. (2014) · Nature
CRISPR and Genetic EngineeringCancer Genomics and Diagnostics
Cited by 640
- Verified
Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
Weissmueller, S., Manchado, E., Saborowski, M., Morris, J. P., Wagenblast, E., Davis, C. A., Moon, S.-H., Pfister, N. T., Tschaharganeh, D. F., Kitzing, T., et al. (2014) · Cell
Cancer-related Molecular PathwaysPancreatic and Hepatic Oncology Research
Cited by 466
- Verified
NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
Ruscetti, M., Leibold, J., Bott, M. J., Fennell, M., Kulick, A., Salgado, N. R., Chen, C.-C., Ho, Y.-J., Sanchez-Rivera, F. J., Feucht, J., et al. (2018) · Science
Immune Cell Function and InteractionTelomeres, Telomerase, and Senescence
Cited by 415
- Verified
A combinatorial strategy for treating KRAS-mutant lung cancer
Manchado, E., Weissmueller, S., Morris, J. P., Chen, C.-C., Wullenkord, R., Lujambio, A., de Stanchina, E., Poirier, J. T., Gainor, J. F., Corcoran, R. B., et al. (2016) · Nature
Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling
Cited by 403
- Verified
SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors
Lu, H., Liu, C., Velazquez, R., Wang, H., Dunkl, L. M., Kazic-Legueux, M., Haberkorn, A., Billy, E., Manchado, E., Brachmann, S. M., et al. (2019) · Molecular Cancer Therapeutics
Protein Tyrosine PhosphatasesMelanoma and MAPK Pathways
Cited by 90
- Verified
Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma
Li, Z., Zhuang, X., Pan, C.-H., Yan, Y., Thummalapalli, R., Hallin, J., Torborg, S., Singhal, A., Chang, J. C., Manchado, E., et al. (2024) · Cancer Discovery
Lung Cancer Treatments and MutationsCancer Cells and Metastasis
Cited by 74
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free